Legacy Emanuel Children's Hospital — Portland, Oregon

Legacy Emanuel Children's Hospital is a clinical research site located in Portland, Oregon, United States 97227.

Crixeo Clinical Trials Trust Score: 85/100 (GOOD). This profile has not yet been claimed by the site owner.

Legacy Emanuel Children's Hospital has participated in 129 clinical trials with 54 currently active.

Therapeutic areas: Advanced Malignant Solid Neoplasm, Ann Arbor Stage III Hodgkin Lymphoma, Ann Arbor Stage III Non-Hodgkin Lymphoma.

Sponsors: National Cancer Institute (NCI), Oregon Health and Science University, Children's Oncology Group.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Portland

Browse all research sites in Oregon · View every site in Portland

Sponsor Feasibility Report

Trust Score: 85/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Legacy Emanuel Children's Hospital?

Legacy Emanuel Children's Hospital has a Crixeo Trust Score of 85/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Legacy Emanuel Children's Hospital conducted?

Legacy Emanuel Children's Hospital has 129 clinical trials on record, with 54 currently active. Their work covers Advanced Malignant Solid Neoplasm, Ann Arbor Stage III Hodgkin Lymphoma, Ann Arbor Stage III Non-Hodgkin Lymphoma.

Is Legacy Emanuel Children's Hospital accredited by Crixeo Clinical Trials?

Legacy Emanuel Children's Hospital has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Legacy Emanuel Children's Hospital?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.